CRF initiates Harmonizing Outcomes with Revascularization and Stents in AMI II …News-Medical.netThe Cardiovascular Research Foundation (CRF) today announced the initiation of the HORIZONS-AMI II randomized trial, evaluating Promus Element platinum-ch…
Steroid Exposure Risk High in 'Allergic Triad'Family Practice News Digital NetworkAmong the children with both asthma and allergic rhinitis, 55% were treated with corticosteroids for both conditions and 38% for one of the two conditions, while …
Beyond the Abstract – Second-line therapy for refractory renal-cell carcinoma …UroTodayThe pivotal phase III placebo-controlled trial with everolimus (RECORD-1 study), carried out in patients relapsed after first-line treatment with TKIs, proved a st…
AACR Annual Oncology Meeting: A Look Into Various AbstractsSeeking AlphaAdding HDAC inhibition to mTOR inhibitors may be a route to circumvent Akt-mediated resistance to mTOR inhibitors. Our results also indicate that this combination may demonstrate b…
6abc.comNew Dry Nasal Spray Approved By FDAFrench TribuneAlthough there were some side-effects that rose during the clinical trials of the spray like nasal discomfort, nosebleed, and headache, it has been found because corticosteroids dampen immune res…
Melanoma With Brain Metastases Benefits From IpilimumabMedscapeThe cohort consisted of 51 patients who were neurologically asymptomatic and not receiving corticosteroids at study entry and 21 patients who were symptomatic and on stable doses of cortico…
Cancer Drugs Improves Bone Health in Post-menopausal WomenBiomed Middle EastHowever, as some anti-cancer drugs are associated with reduced bone mineral density and an increased risk of fractures, it was important to discover whether everolimus and exem…
USA TODAYFDA Approves 'Dry' Nasal Spray for AllergyWebMDLiquid forms of this and other intranasal corticosteroids have been available for years. But many patients don't like them, says Gary Gross, MD, co-founder of the Dallas Allergy & …
RTT NewsTeva Wins FDA Approval For Qnasl Nasal Aerosol To Treat Allergic RhinitisRTT NewsIntra-nasal corticosteroids are recommended as first-line therapy for allergic rhinitis and the only available option on the market before the approval of Qnasl (b…
Boston Scientific Supports Trial to Evaluate Platinum Chromium Coronary StentsRTT News(BSX: News ) announced its support of the HORIZONS II AMI clinical trial, which is designed to evaluate the safety and efficacy of the PROMUS Element Plus Everolimus-…